KAZIA THERAPEUTICS-SPON ADR (KZIA)

US48669G1058 - ADR

0.8958  -0.34 (-27.76%)

After market: 0.85 -0.05 (-5.11%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

KAZIA THERAPEUTICS-SPON ADR

NASDAQ:KZIA (7/12/2024, 9:39:03 PM)

After market: 0.85 -0.05 (-5.11%)

0.8958

-0.34 (-27.76%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month156.02%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap26.67M
Shares
PEN/A
Fwd PE118.23
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

KZIA Daily chart

Company Profile

Kazia Therapeutics Ltd is a AU-based company operating in Biotechnology industry. The company is headquartered in Sydney, New South Wales. Kazia Therapeutics Limited is an oncology focused drug development company. The firm is engaged in the pharmaceutical research and development. Its lead program includes Paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of vascular endothelial growth factor receptor 3 (VEGFR3), which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. EVT801 is an inhibitor of VEGFR3, a cellular receptor for VEGF. The Company’s drug candidates are designed to treat disease, such as brain cancer, renal cancer, and liver cancer.

Company Info

KAZIA THERAPEUTICS-SPON ADR

Three International Towers Level 24,, 300 Barangaroo Avenue

Sydney NEW SOUTH WALES 2000

P: 1161298780088

CEO: James Garner

Employees: 0

Website: https://www.kaziatherapeutics.com/

KZIA News

ChartMill News Image9 hours ago - ChartmillKeep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

ChartMill News Image11 hours ago - ChartmillThe trading volume of these stocks is deviating from the norm in today's session.

Unusual volume stocks in Friday's session

ChartMill News Image12 hours ago - ChartmillWhat's going on in today's session

Which stocks are moving on Friday?

ChartMill News Image14 hours ago - ChartmillGapping stocks in Friday's session

Gapping stocks in Friday's session

News Image14 hours ago - InvestorPlaceFrom Pennies to Dollars: 3 Sub-$5 Stocks Set to Explode Higher

If you’ve read all the warnings and still want to jump into some of the top penny stocks to buy, focus on the key fundamentals.

ChartMill News Image16 hours ago - ChartmillWhich stocks are moving before the opening bell on Friday?

Which stocks are moving before the opening bell on Friday?

KZIA Twits

Here you can normally see the latest stock twits on KZIA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example